ENVALITH
片倉コープアグリ株式会社 logo

katakura & co-op agri corporation

4031Standard MarketChemicals

片倉コープアグリ株式会社 logo
katakura & co-op agri corporation4031

Business

Katakura Co-op Agri Co., Ltd. is a long-established fertilizer manufacturer founded in 1920, which took its current name following a business integration with Co-op Chemical in 2015. The company has 6 consolidated subsidiaries and 1 equity-method affiliate. Its core operation is the Fertilizer Business (approximately 82% of net sales), which manufactures and sells Compound & Chemical Fertilizers, Paste Fertilizer, and other products. It also operates a Chemical Products Business handling cosmetic ingredients and phosphoric acid products, a Real Estate Business including a leased building in Shibuya-ku, Tokyo, and Other Businesses such as food products and transportation. Its main customer is the National Federation of Agricultural Cooperative Associations (JA Zen-Noh), which accounted for 62.4% of net sales in FY2026 (ending March 2026). The Tsukuba Research Institute serves as its R&D hub, driving the development of smart agriculture and soil analysis technologies.

Business Model

In the Fertilizer Business, which accounts for approximately 82% of net sales, the company adopts a vertical cooperative distribution model, procuring raw materials from and selling products through JA Zen-Noh. It aims to secure sales volume while passing on costs through price revisions. In the Chemical Products Business, the company is expanding high-value-added products such as synthetic mica and cosmetic ingredients both domestically and internationally, aiming to improve profit margins. The Real Estate Business generates stable cash flow through rental income from the "KCA SHIBUYA bldg." and plays a role in supporting the financial foundation during the structural reform period.

Company Strengths

Since its founding in 1920, the company has built a nationwide network of branches and sales offices, maintaining long-term raw material procurement and product sales relationships with JA Zen-Noh, Marubeni, and others. In FY2026 (ending March 2026), sales to JA Zen-Noh reached ¥26,630 million (62.4% of net sales), and the company possesses a stable sales base through cooperative distribution channels.

Centered on the Tsukuba Research Institute, established in 1986, the company invested ¥319 million in R&D expenses in FY2026 (ending March 2026) to develop proprietary products such as Paste Fertilizer, slow-release fertilizers, Biostimulant Materials, and synthetic mica. The company has also launched a Soil Diagnostic Service utilizing near-infrared spectroscopy and AI, advancing technological development into the agricultural solutions field.

The Chemical Products Business recorded net sales of ¥7,677 million and segment profit of ¥369 million in FY2026 (ending March 2026), expanding high-value-added products such as HALAL-certified cosmetic ingredients and synthetic mica into Europe and Asia. The Real Estate Business recorded segment profit of ¥184 million following the completion of the "KCA SHIBUYA bldg." (August 2025), functioning as a stable revenue source that complements fluctuations in earnings from the Fertilizer Business.

ENVALITH's Perspective

Net loss attributable to owners of parent for FY2026 (ending March 2026) came to ¥1,227 million, a significant deterioration from the prior-period profit of ¥350 million. However, this was due to the recognition of extraordinary losses totaling ¥1,980 million in structural reform costs, comprising a ¥1,210 million provision for production facility dismantling costs, ¥382 million in fixed asset impairment, ¥143 million in additional severance payments, and ¥243 million in inventory valuation losses. Operating profit of ¥504 million exceeded the medium- to long-term growth strategy plan target of ¥450 million, reflecting the success of early monetization of the Shibuya Building and cost improvements in the Fertilizer Business. The structural reform costs are one-off in nature, and it will be necessary to monitor the recovery in earnings from FY2027 (ending March 2027) onward.

The Fertilizer Business secured net sales of ¥35,164 million (up 4.4% year on year) through price revisions in June and November 2025 and increased sales volume, but segment profit came to only ¥6 million (down 79.0% year on year). Increased system-related costs and the impact of inventory valuation weighed on profit. As an external factor, raw material prices have continued to remain elevated, and establishing a low-cost structure through the reorganization of production sites (discontinuation of production at 5 plants) will be key to earnings improvement from FY2027 (ending March 2027) onward. The shortfall against the sales plan (actual ¥42,651 million versus planned ¥45,000 million) was mainly due to the shortfall in Fertilizer sales volume against plan, and uncertainty on the demand side remains.

The consolidated earnings forecast for FY2027 (ending March 2027) anticipates a significant recovery, with net sales of ¥46,000 million (up 7.8% year on year), operating profit of ¥800 million (up 58.5%), and net profit of ¥500 million. The main factors behind the improvement are fixed-cost reductions from the completed reorganization of production sites and the start of operations under the separated production and sales system. On the other hand, procurement risks and price increase impacts for raw materials and supplies associated with rising tensions in the Middle East have not been incorporated into the forecast, as they are deemed "difficult to reasonably estimate," leaving downside risk from external factors. Dividends are planned at ¥28 per share (an increase from ¥20 in the prior period), indicating a shareholder return policy with a dividend payout ratio of 50.2%.

Growth Strategy

With fertilizer production base restructuring and chemical products overseas expansion as twin pillars, the company aims to achieve operating profit of ¥1,090 million in FY2028 (ending March 2028)

Ceased production at 5 of the 6 target plants and consolidated production items to significantly reduce fixed costs. Concurrently promoting the introduction of a manufacturing-sales separation system and rationalization of administrative departments. Restructuring costs of ¥1,980 million were already recorded in FY2026 (ending March 2026), and this is the most critical initiative directly linked to profitability improvement from FY2027 (ending March 2027) onward.

Launched a Soil Diagnostic Service utilizing near-infrared spectroscopy and AI, and built a proposal-based sales model leveraging remote sensing. Through expansion into the biostimulant field, the company is promoting a transition from simple fertilizer sales to a business model that solves agricultural challenges.

Promoting expansion of sales channels for HALAL-certified cosmetic ingredients for Southeast Asia through an Indonesian sales trading company, strengthening the expansion of synthetic mica for Europe and Asia, and developing next-generation functional materials. The company is also expanding its business domain with strategic investments such as M&A in view. In FY2026 (ending March 2026), segment sales decreased 1.5% year on year due to a decline in sales volume of phosphoric acid and feed-grade calcium phosphate.

Through the full-scale operation of "KCA SHIBUYA bldg.," completed in August 2025, the company recorded segment profit of ¥184 million in FY2026 (ending March 2026). The company continues to optimize the utilization of its held assets, functioning as a revenue source that stably supports the financial base during the period of structural reform.

Last updated: July 19, 2026